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nevertheless, to learn that Robert Graves was a relative latecomer. Caleb Parry had described the disease in 1786,'' though the case was not published until 1825, three years after his death, but 10 years before Graves's account. Sir William Osler championed Parry's priority to such good effect that Parry's disease entered the literature; however, the competition was too great for it to replace Graves' disease. However, we would ask you to spare a thought for Giuseppe Flajani, who was responsible for the first published account in 1802.13 But he really didn't stand a chance with the description submerged in the third volume of his collected observations.
The eponymous naming of diseases and syndromes should, therefore, never be taken to imply priority of description -that would be far too hazardous an assumption. All too often it is a matter of luck, the laurels being awarded to the person, or author of the description (however incomplete), who the world sees as having been in the right place at the right time to create the necessary impact. Should eponym and priority happen to conicide we have cause for rejoicing. Thus the eponym must, sadly, be regarded as nothing more or less than a convenient shorthand to communication.
When, however, we move from diseases and syndromes (which usually have been sitting in the wings awaiting discovery) to tests, techniques, and the like (which have to be invented) we find ourselves in an infinitely more perilous part of the minefield.
In 1881 Newel1 Martin of Johns Hopkins University devised an isolated working heart model. l4 Although his system was complex, requiring oxygenation of the perfusing blood by the lungs, it did nevertheless antedate the now standard isolated working rat heart model of Neely et all' by some 86 years. Neely et a1 did not cite Martin's paper. There was no direct line of descent from Martin to Neely and his group, so no debt was owed to him. In 1967 it was no longer common practice to write fairly exhaustive historical introductions to scientific papers and, presumably, the group did not include a professional medical historian. Martin's work, advanced though it was, must therefore be relegated to an honourable place in medical history. (A more detailed account of Martin's work has been given by Opie,I6 though we have identified an earlier paper than the one he cited.)
Langendorffi7 was more fortunate, since his isolated perfused mammalian heart was simple, more suited to metabolic studies, and is still with us, with his name attached, as the standard model. Another survivor is the Krebs-Henseleit buffer solution,'8 yet how many of us have read LangendorlT' s paper or those of Krebs and Henseleit, let alone understood them? We would argue that, since both model and solution have been in use for a sufficiently long time and no one has questioned the originators' priority, there is a strong case for ceasing to cite these references in the bibliography. Other considerations apart, it would probably be the honest thing for most of us to do.
The situation becomes considerably more complex in the case of our next example. The technique of delineating a myocardial infarct by tetrazolium staining for dehydrogenases was originally described by Sandritter and Jestadt in 1958 -in the German literature. They used triphenyltetrazolium which forms a red formazan product in the presence of dehydrogenases. Five years later Nachlas and Shnitka'" published -in the American literature -a modification in which nitroblue tetrazolium was used to form a blue formazan product to improve the delineation. They acknowledged the German workers, and said that their own work "confirms and extends the findings of the European investigators". Which paper is to be cited? Unfortunately, the matter does not end there. In 1983, Mullane et al" used Sandritter and Jestadt's technique, but attributed it to Lie et al." A clear case of misattribution? Apparently not, since they had used dogs and Lie et a1 had also used dogs, whereas Sandritter and Jestadt had used human and guinea pig tissue. This is splitting hairs. Surely it is the first description (and successful use) of the technique that is important, not the subsequent minor modifications and fine tuning? Thereafter signijicanr modifications should be cited as "Smith's technique as modified by Jones". Common sense is obviously necessary, but we should bear in mind that we are in the business of scientific accuracy, not historical pedantry.
Finally, we come to a reprehensible aspect of citationwhat might be termed "political citation". In our experience, authors are often requested by reviewers to cite further papers in their typescripts. The usual reason is the perfectly valid one that the reviewer considers the citations to be biased in favour of the author's viewpoint. However, it sometimes happens that the reviewer is anxious to see his own work cited and, if priority is involved, the peer review system then becomes decidedly counterproductive. Misattribution may result from the reverse of this process, when the author has a fairly shrewd idea of who the reviewer will be and proceeds to pack his reference list with citations that he feels will ensure a favourable review, or a successful grant application. Alas, we believe that both of these practices do occur.
With the advent of computerised literature searches and the move towards a more concise form in scientific publication, we earnestly hope that controversies over priority will fade into the past, and that it will become progressively easier to detect biases in attribution and misattributions from whatever cause.
